F10 and atrial fibrillation: This observational study did not show a significant impact of atorvastatin on trough and peak anti‐Xa activity in direct oral factor Xa inhibitors‐treated patients with AF, which suggests that atorvastatin could be safely co‐administrated with direct oral factor Xa inhibition.